×
ADVERTISEMENT

ImmunoGen

FDA Approves Elahere to Treat Platinum-Resistant Ovarian Cancer

Mirvetuximab soravtansine-gynx was approved to treat adults with folate receptor alpha-positive, platinum-resistant ...

NOVEMBER 21, 2022

Load more